Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer (APPAHOCA)

January 15, 2019 updated by: Centre Francois Baclesse
The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France, 14000
        • Centre Francois Baclesse
      • Caen, France, 14000
        • CHU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient with cancer
  • Patient over 70 years old hospitalized 48 hours or more
  • Patient identified as eligible for medical prescription of Adapted physical activity
  • Mastery of the French language ;
  • Patient affiliated to a social security scheme
  • Patient giving written consent

Exclusion Criteria:

  • Patient totally unable to communicate
  • Patient in terminal palliative care
  • Patient with a size <1m35 or> 2m and / or a weight> 130kg
  • Patient unable to perform Adapted physical activity sessions
  • Patient unable to wear a restraint harness.
  • Patient deprived of liberty or under guardianship
  • Patient unable to comply with protocol requirements for geographical, social or psychopathological reasons

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Adapted walking platform
The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient adherence to use a walking Platform
Time Frame: 2 days
Adapted physical activity on a walking platform will be considered feasible if > or = to 70% of patients perform > or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting > or = to 48h
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 29, 2018

Primary Completion (Actual)

October 11, 2018

Study Completion (Actual)

December 11, 2018

Study Registration Dates

First Submitted

March 12, 2018

First Submitted That Met QC Criteria

March 21, 2018

First Posted (Actual)

March 22, 2018

Study Record Updates

Last Update Posted (Actual)

January 16, 2019

Last Update Submitted That Met QC Criteria

January 15, 2019

Last Verified

March 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APPAHOCA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oncology

Clinical Trials on Adapted walking platform

3
Subscribe